Skip to content
FDA Approval: TT Fields for NSCLC episode artwork

Dec 13, 2024 37 min

FDA Approval: TT Fields for NSCLC

from Lung Cancer Considered Hosted by IASLC

Tumor Treating Fields (TTFields) is a non-invasive cancer treatment that uses alternating electric fields to disrupt the ability of cancer cells to divide. TTFields can slow down tumor growth and spread, and may help people live longer than chemotherapy alone. In this episode of Lung Cancer Considered, host Dr. Narjust Florez discusses this new therapy and the Phase III LUNAR study that led to its FDA approval. Guest: Dr. Ticiana Leal is an Associate Professor and serves as Director of the Thoracic Medical Oncology Program in the Department of Hematology and Medical Oncology at Emory University School of Medicine.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

FDA Approval: TT Fields for NSCLC

0:00 37:48

No transcript yet.

Requests help us decide what to transcribe next.

Share this episode

Similar podcasts

Lung Cancer Update for Nurses Dr Neil Love Featuring one-on-one interviews conducted by Dr Neil Love with national lung cancer clinical investigators and oncology nurses, this series provides practicing clinicians including nurses and nurse practitioners with valuable information and current clinical management strategies that can be applied to optimize patient care.

Frequently asked questions

How long is this episode of Lung Cancer Considered?

This episode is 37 minutes long.

When was this Lung Cancer Considered episode published?

This episode was published on December 13, 2024.

Can I download this Lung Cancer Considered episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.